William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories
-
William Blair on SpaceX (SPCX): 'AI Feeding Frenzy Is Right in SpaceX's Wheelhouse'
-
William Blair on Netflix (NFLX): 'Decent Quarter, but Fourth-Quarter Guidance Weighs on Shares Due to Slower Advertising Product(s) Rollout and Integrations'
-
Teknova prices $40M public offering at $5.00 per share
-
Teknova launches public stock offering on Nasdaq
-
William Blair Downgrades Braze Inc (BRZE) to Market Perform
-
Morgan Stanley Capital Partners buys New Jersey equipment services firm
-
William Blair Starts Midera Food Processing (MFP) at Outperform
-
William Blair Reiterates Market Perform Rating on Torrid Holdings Inc (CURV)
-
William Blair Expands Investment Banking Platform with Acquisition of Armentum Partners
-
Central Garden & Pet acquires Burpee seed brand
-
Central Garden & Pet Acquires Burpee, an Iconic Brand in the Packet Seed and Young Plant Categories
-
William Blair Investment Management Completes Conversion of Emerging Markets Fixed Income Mutual Fund to Active ETF
-
Form 497 WILLIAM BLAIR FUNDS
-
Form 497K William Blair ETF Trust
-
Form 497 William Blair ETF Trust
-
William Blair Starts Kardigan Inc (KARD) at Outperform
-
William Blair Starts Arcus Biosciences (RCUS) at Outperform
-
William Blair Starts Faeth Therapeutics (FTH) at Outperform
-
William Blair Starts Rhythm Pharmaceuticals (RYTM) at Outperform
-
William Blair Starts WAVE Life Sciences (WVE) at Outperform
-
William Blair Starts Palvella Therapeutics (PVLA) at Outperform
-
William Blair Starts Ideaya Biosciences (IDYA) at Outperform
-
William Blair Starts Immunome Inc. (IMNM) at Outperform
-
William Blair Starts Revolution (RVMD) at Outperform
-
William Blair Starts Edgewise Therapeutics (EWTX) at Outperform
-
William Blair Starts Tango Therapeutics Inc. (TNGX) at Outperform
-
William Blair Starts Cytokinetics (CYTK) at Outperform
-
William Blair Downgrades Clarivate Analytics (CCC) to Market Perform
-
William Blair launches first ETFs on NYSE for international markets
-
William Blair Investment Management Launches First ETFs, Expanding International and Emerging Markets Expertise to Active ETF Market
-
William Blair Starts Marex Group PLC (MRX) at Outperform
-
William Blair Resumes Jasper Therapeutics (JSPR) at Outperform
-
PSP Capital sells StormTrap to Advanced Drainage Systems for $530M
-
PSP Capital Announces Sale of StormTrap to Advanced Drainage Systems
-
Form CERT William Blair ETF Trust
-
Rhône Announces Agreement to Sell Paragon Films to Atlantic Ridge Capital and Grafine Partners
-
Google DeepMind’s Nature Study on Watermarking AI-Designed Proteins Validated with Carterra HT-SPR
-
Dental firm vVardis reveals revenue surge in US IPO filing
-
Buy this consumer stock amid 'muted valuation,' analyst says
-
William Blair on SpaceX (SPCX): 'Indoor Coverage Problem Closer to Solved?'
-
William Blair Downgrades Alignment Healthcare Inc (ALHC) to Market Perform
-
SpaceX takes aim at US wireless carriers with spectrum acquisition
-
William Blair: 'One wild card could be a potential sale of Starbucks Japan, which could help fund a Chipotle acquisition'
-
William Blair Downgrades Latham Group Inc. (SWIM) to Market Perform
-
RIAs Plan to Broaden Portfolios Beyond U.S., William Blair Investment Management Survey Finds
-
Carterra Advances Lab-In-The-Loop Drug Discovery Through New Scientific Collaboration
-
William Blair Reiterates Market Perform Rating on SiteOne Landscape Supply (SITE)
-
William Blair Downgrades Option Care Health (OPCH) to Market Perform
-
William Blair: 'view BridgeBio as becoming a core smidcap biotech holding'
-
AST SpaceMobile shares jump on carrier test wins


